myNewbornDNA

750

myNewbornDNA is a neonatal screening genetic test based on whole exome sequencing that accurately detects more than 390 diseases that can affect a newborn in the early stages of life and allows early detection before the symptoms appear.

myNewbornDNA is a genetic test that requires a medical prescription. In case you cannot obtain the prescription from your physician, you can contact Veritas and our medical team will provide a genetic consultation and prescribe the test.

 

Request consultation

Category:

Description

myNewbornDNA is a neonatal screening genetic test that analyzes the DNA of a newborn through the sequencing of the complete exome or WES (Whole Exome Sequencing) to determine if it presents any pathogenic variant related to more than 390 actionable conditions that may of appear during childhood, allowing the specialist to improve medical care. Knowing this risk allows us to implement the necessary monitoring or treatment in each case, anticipating the appearance of symptoms.

 

What will you receive?

  • Analysis of 407 genes related to genetic and metabolic diseases that appear in the first years of life.
  • Report providing the complete results about the variants detected and the implications of each.
  • Genetic specialist will interpret the information of the screening.

For more information please click on the additional information tab.

I want myNewbornDNA, how do I do organize the test?

Buy your kit. You will receive a confirmation email along with the necessary documentation and a call from our Patient Care service to explain the procedure.

The specialist or prescribing physcian must request and approve the genetic test.

At Veritas we perform the sequencing of the sample as well as the genetic analysis and interpretation necessary to generate the report.

We prepare a complete and understandable report that we will send to the prescribing physician. He will explain the report and the results.

Why choose myNewbornDNA?

Because it is a complete genetic test that detects accurately more than 390 diseases that can affect the newborn in the first stages of life.

Because you will benefit from working with the world leader in genetic testing, Veritas is The Genome Company, has more than 15 years of experience in genetic sequencing and has a multidisciplinary team of experts.

Because you are accompanied by a genetic specialist throughout the entire process. Veritas has a team of genetic counselors who will support you and your doctor at all times.

Additional Information

WHO IS THIS TEST FOR?

This postnatal genetic test is for newborns and children during early childhood.

HOW ARE THE REPORTED DISEASES CLASSIFIED?

The diseases that are reported are included in the following areas: metabolic, endocrine, autoimmune, deaf, neurological and others, among which are cystic fibrosis or biotinidase deficiency.

WHY VERITAS?

Veritas is The Genome Company . By removing barriers in genetic screening and in the sequencing of the entire genome, we empower people and doctors to make informed decisions in order to maximize the quality and duration of life.

Our CLIA-certified laboratory has a world-class team that includes doctors, genetic counselors, geneticists, developers and bioinformatics with decades of clinical experience.

  • Whole Exome Sequencing in illumina HiSeq X10 and NovaSeq 6000 platforms.
  • Average coverage 110x sequencing more than 97% at 20x and reaching a coverage of 300x in genes of interest.
  • The laboratory complies with the CLIA regulation (CLIA # 22D2089381) and have CAP accreditation.
  • All reports are reviewed by our expert medical team that has more than 10 years of experience in genome and complete exome sequencing, including members of the Personal Genome Project of the Harvard Medical School.

MORE INFORMATION

You may also like…